01Clene reported Q3 2026 earnings per share of $0.05, beating estimates by $0.52, while revenue of $56.0K missed the $65.4K forecast.
02The stock trades at $3.83 with a $64.9M market capitalization after the 111% earnings surprise.
03Prior quarters showed significant losses, with Q2 missing estimates by $0.80 and Q1 missing by $0.03 per share.
04The company's earnings trajectory has been volatile, swinging from large losses to a small profit in one quarter.
Earnings Results
Clene (NASDAQ:CLNN) reported quarterly earnings results on November 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.05, beating the consensus estimate of $-0.47 by $0.52 per share. Revenue came in at $56.0K, missing the estimate of $65.4K.
Company Overview
Clene's stock moved following the earnings release. The stock currently trades at $3.83 with a market capitalization of $64.9M.
Clene's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
The 111% beat relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Clene should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.